NORTH AMERICA AND EUROPE MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET ANALYSIS

North America And Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type (Hand (Resectoscope, Linear Cutter, Insufflators, Curved Stapler, Endoscopic Trocars, Prostatic Retractor, Cryoablation Device, Others), Monitoring & Visualization (Cameras & Video Support, Endoscopic Trocars with Optical View), Powered (Electrosurgical Unit, Lasers)), By Application (Laparoscopy, Robotics, Brachytherapy, Cryosurgery), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) and by Region (North America, and Europe)

Published In : Aug 2023
Code : CMI4079
Pages :140
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

North America and Europe Minimally Invasive Prostate Cancer Surgery Market - Driver

Increasing product launches by key market players are expected to aid the growth of the North America and Europe minimally invasive prostate cancer surgery market over the forecast period. For instance, on April 26, 2023, Orthofix Medical, a U.S.-based spine and orthopaedics company, announced the launch of Lattus Lateral Access System and the Fathom Pedicle-Based Retractor System for minimally invasive surgical procedures. The two latest access retractor systems are designed to aid surgeons during minimally invasive surgical procedures to expand Orthofix Medical’s offering of access solution.

North America and Europe Minimally Invasive Prostate Cancer Surgery Market: Restraints

Increasing product recalls by regulatory authorities: Inefficiency of surgery in treating advanced stage cancer is expected to hinder the market growth over the forecast period. For instance, inefficiency of surgery in treating advanced stage cancer is expected to hinder the growth of the North America and Europe minimally invasive prostate cancer surgery market. Surgical procedures is more suitable when the cancer is localized within the prostate gland. However, as the cancer metastases to nearby lymph nodes and bones, surgery becomes incapable of treating it. Moreover, many surgeons are hesitant in adopting new robotic technology and prefer the traditional methods, which is also expected to limit the market growth.